Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 11.07.17 in Vol 6, No 7 (2017): July

This paper is in the following e-collection/theme issue:

Works citing "Natural Compounds for the Treatment of Psoriatic Arthritis: A Proposal Based on Multi-Targeted Osteoclastic Regulation and on a Preclinical Study"

Shiqiang Deng, Jianwen Cheng, Jinmin Zhao, Felix Yao, Jiake Xu

JMIR Res Protoc 2017 (Jul 11); 6(7):e132 

According to Crossref, the following articles are citing this article (DOI 10.2196/resprot.7636):

(note that this is only a small subset of citations)

  1. Liu C, Cao Z, Zhang W, Tickner J, Qiu H, Wang C, Chen K, Wang Z, Tan R, Dong S, Xu J. Lumichrome inhibits osteoclastogenesis and bone resorption through suppressing RANKL‐induced NFAT activation and calcium signaling. Journal of Cellular Physiology 2018;233(11):8971
    CrossRef
  2. Wang Q, Yao L, Xu K, Jin H, Chen K, Wang Z, Liu Q, Cao Z, kenny J, Liu Y, Tickner J, Xu H, Xu J. Madecassoside inhibits estrogen deficiency‐induced osteoporosis by suppressing RANKL‐induced osteoclastogenesis. Journal of Cellular and Molecular Medicine 2019;23(1):380
    CrossRef
  3. Zhou L, Liu Q, Hong G, Song F, Zhao J, Yuan J, Xu J, Tan RX, Tickner J, Gu Q, Xu J. Cumambrin A prevents OVX‐induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways. The FASEB Journal 2019;33(6):6726
    CrossRef
  4. Yang M, Xie J, Lei X, Song Z, Gong Y, Liu H, Zhou L. Tubeimoside I suppresses diabetes-induced bone loss in rats, osteoclast formation, and RANKL-induced nuclear factor-κB pathway. International Immunopharmacology 2020;80:106202
    CrossRef
  5. Song D, Cao Z, Tickner J, Qiu H, Wang C, Chen K, Wang Z, Guo C, Dong S, Xu J. Poria cocos polysaccharide attenuates RANKL-induced osteoclastogenesis by suppressing NFATc1 activity and phosphorylation of ERK and STAT3. Archives of Biochemistry and Biophysics 2018;647:76
    CrossRef
  6. Song D, Cao Z, Huang S, Tickner J, Li N, Qiu H, Chen X, Wang C, Chen K, Sun Y, Dong S, Xu J. Achyranthes bidentata polysaccharide suppresses osteoclastogenesis and bone resorption via inhibiting RANKL signaling. Journal of Cellular Biochemistry 2018;119(6):4826
    CrossRef
  7. Nguyen UT, Nguyen LTH, Kim B, Choi M, Yang I, Shin H, Da Silva Filho AA. Natural Compound Mixture, Containing Emodin, Genipin, Chlorogenic Acid, Cimigenoside, and Ginsenoside Rb1, Ameliorates Psoriasis-Like Skin Lesions by Suppressing Inflammation and Proliferation in Keratinocytes. Evidence-Based Complementary and Alternative Medicine 2020;2020:1
    CrossRef
  8. Lu Q, Jiang C, Hou J, Qian H, Chu F, Zhang W, Ye M, Chen Z, Liu J, Yao H, Zhang J, Xu J, Wang T, Fan S, Wang Q. Patchouli Alcohol Modulates the Pregnancy X Receptor/Toll-like Receptor 4/Nuclear Factor Kappa B Axis to Suppress Osteoclastogenesis. Frontiers in Pharmacology 2021;12
    CrossRef
  9. Chen D, Chu F, Zhang G, Wang Q, Li Y, Zhang M, He Q, Yang J, Wang H, Sun P, Xu J, Chen P. 12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation. International Immunopharmacology 2021;101:108177
    CrossRef